Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076143416> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2076143416 endingPage "268" @default.
- W2076143416 startingPage "263" @default.
- W2076143416 abstract "Gemfibrozil is a widely used hypolipidemic drug in humans that causes peroxisome proliferation and hepatocarcinogenesis in rodents. The induction of hepatomegaly and hepatic peroxisome proliferation (measured as peroxisomal acyl CoA oxidase activity), was determined and compared to another peroxisome proliferator, WY-14,643 (0.1% in the diet) in male F344 rats. In a 21-day study, dietary no-observable-effect and lowest-observable-effect levels of gemfibrozil for both hepatomegaly and peroxisome proliferation were 0.002% and 0.005%, respectively. In a 42-day study, dietary concentrations of 0.9–2.0% gemfibrozil induced a similar magnitude of hepatomegaly to WY-14,643 (2.3-fold) but a higher level of peroxisome proliferation (16–18-fold) than the maximum induction for WY-14,643 (13-fold). The plateau in magnitude of gemfibrozil-induced peroxisome proliferation across the 0.9–2.0% dietary concentrations was associated with a plateau in serum concentration of gemfibrozil (2̃0 μg/ml), similar to concentrations reported in human subjects receiving oral gemfibrozil. These results indicate that maximal induction of peroxisome proliferation by gemfibrozil can exceed that of a more potent compound such as WY-14,643, and further suggest that maximal induction of peroxisome proliferation can be limited by steady-state serum concentrations. Moreover, the reported lack of hepatic responses to gemfibrozil in humans is unlikely to be the result of inefficacy or unavailability of this drug, compared to other peroxisome proliferators, in rodents." @default.
- W2076143416 created "2016-06-24" @default.
- W2076143416 creator A5018569092 @default.
- W2076143416 creator A5035005657 @default.
- W2076143416 creator A5066808612 @default.
- W2076143416 creator A5074743135 @default.
- W2076143416 creator A5082534774 @default.
- W2076143416 date "1995-11-01" @default.
- W2076143416 modified "2023-09-26" @default.
- W2076143416 title "Gemfibrozil-induced peroxisome proliferation and hepatomegaly in male F344 rats" @default.
- W2076143416 cites W1970530154 @default.
- W2076143416 cites W1978129373 @default.
- W2076143416 cites W1986517759 @default.
- W2076143416 cites W1993851808 @default.
- W2076143416 cites W2009998389 @default.
- W2076143416 cites W2035534064 @default.
- W2076143416 cites W2077259648 @default.
- W2076143416 cites W2087936004 @default.
- W2076143416 cites W2094210881 @default.
- W2076143416 cites W2163303352 @default.
- W2076143416 cites W2341665659 @default.
- W2076143416 cites W5739282 @default.
- W2076143416 doi "https://doi.org/10.1016/0304-3835(95)03987-8" @default.
- W2076143416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7497472" @default.
- W2076143416 hasPublicationYear "1995" @default.
- W2076143416 type Work @default.
- W2076143416 sameAs 2076143416 @default.
- W2076143416 citedByCount "20" @default.
- W2076143416 countsByYear W20761434162013 @default.
- W2076143416 countsByYear W20761434162014 @default.
- W2076143416 countsByYear W20761434162022 @default.
- W2076143416 crossrefType "journal-article" @default.
- W2076143416 hasAuthorship W2076143416A5018569092 @default.
- W2076143416 hasAuthorship W2076143416A5035005657 @default.
- W2076143416 hasAuthorship W2076143416A5066808612 @default.
- W2076143416 hasAuthorship W2076143416A5074743135 @default.
- W2076143416 hasAuthorship W2076143416A5082534774 @default.
- W2076143416 hasConcept C126322002 @default.
- W2076143416 hasConcept C127078168 @default.
- W2076143416 hasConcept C134018914 @default.
- W2076143416 hasConcept C170493617 @default.
- W2076143416 hasConcept C187345961 @default.
- W2076143416 hasConcept C2778163477 @default.
- W2076143416 hasConcept C2778670441 @default.
- W2076143416 hasConcept C2779745421 @default.
- W2076143416 hasConcept C71924100 @default.
- W2076143416 hasConcept C86803240 @default.
- W2076143416 hasConcept C98274493 @default.
- W2076143416 hasConceptScore W2076143416C126322002 @default.
- W2076143416 hasConceptScore W2076143416C127078168 @default.
- W2076143416 hasConceptScore W2076143416C134018914 @default.
- W2076143416 hasConceptScore W2076143416C170493617 @default.
- W2076143416 hasConceptScore W2076143416C187345961 @default.
- W2076143416 hasConceptScore W2076143416C2778163477 @default.
- W2076143416 hasConceptScore W2076143416C2778670441 @default.
- W2076143416 hasConceptScore W2076143416C2779745421 @default.
- W2076143416 hasConceptScore W2076143416C71924100 @default.
- W2076143416 hasConceptScore W2076143416C86803240 @default.
- W2076143416 hasConceptScore W2076143416C98274493 @default.
- W2076143416 hasIssue "2" @default.
- W2076143416 hasLocation W20761434161 @default.
- W2076143416 hasLocation W20761434162 @default.
- W2076143416 hasOpenAccess W2076143416 @default.
- W2076143416 hasPrimaryLocation W20761434161 @default.
- W2076143416 hasRelatedWork W1970158294 @default.
- W2076143416 hasRelatedWork W1976883865 @default.
- W2076143416 hasRelatedWork W2023069026 @default.
- W2076143416 hasRelatedWork W2047192070 @default.
- W2076143416 hasRelatedWork W2049983395 @default.
- W2076143416 hasRelatedWork W2067382803 @default.
- W2076143416 hasRelatedWork W2076143416 @default.
- W2076143416 hasRelatedWork W2121614730 @default.
- W2076143416 hasRelatedWork W2410569365 @default.
- W2076143416 hasRelatedWork W2490132098 @default.
- W2076143416 hasVolume "97" @default.
- W2076143416 isParatext "false" @default.
- W2076143416 isRetracted "false" @default.
- W2076143416 magId "2076143416" @default.
- W2076143416 workType "article" @default.